September 2026
The US glioblastoma multiforme treatment market reached USD 850.30 million in 2026, featuring leading US glioblastoma multiforme treatment market companies such as Amgen, Inc., Pfizer Inc., Arbor Pharmaceuticals, LLC.
March 2026
The global glioblastoma multiforme treatment market size was estimated at USD 3.01 billion in 2025 and is expected to hit around USD 6.48 billion by 2035, growing at a CAGR of 7.97%
September 2026
The global postmenopausal osteoporosis treatment market size is calculated at USD 14.20 billion in 2026 and is projected to hit around USD 22.51 billion by 2035 with a CAGR of 5.26%.
September 2026
The substance abuse treatment market size is expected to increase from USD 36.83 billion by 2034 from USD 17.23 billion in 2026 with a solid CAGR of 10.05%.
September 2026
The rare musculoskeletal disorder treatments market is growing as innovation targets therapies for underserved and complex conditions.
September 2026
The global chronic venous occlusions treatment market size is estimated to surge around USD 11.52 billion by 2035 increasing from USD 7.77 billion in 2026, with a CAGR of 4.47%.
September 2026
The global ischemia reperfusion injury treatment market size was evaluated at USD 1.19 billion in 2026 and is predicted to hit around USD 2.07 billion by 2035, growing at a CAGR of 6.32%.
September 2026
The industrial wastewater treatment market size is projected to hit around USD 34.11 billion by 2034 from USD 20.63 billion in 2026, with a CAGR of 6.44%.
April 2026
The global sinusitis treatment market size was evaluated at USD 2.54 billion in 2025 and is predicted to surpass around USD 4.44 billion by 2035, with a CAGR of 5.74%.
February 2026
The point-of-use water treatment systems market size was valued at USD 37.68 billion in 2025 and is expected to hit around USD 89.83 billion by 2035, with a CAGR of 9.08%.
July 2025
The produced water treatment market size was estimated at USD 8.82 billion in 2024 and is projected to surpass around USD 18.58 billion by 2034 with a CAGR of 7.73%.
July 2025
The global acute migraine treatment market size was valued at USD 3.46 billion in 2024 and is expected to surge around USD 10.08 billion by 2034 with a CAGR of 11.30%.
June 2025
The global glaucoma treatment market size is expected to attain around USD 8.66 billion by 2034, increasing from USD 6.51 billion in 2024, with a CAGR of 2.86%.
September 2026
The pruritus therapeutics market size stood at USD 12.26 billion in 2026, with major pruritus therapeutics market companies including Bristol-Myers Squibb, Novartis AGÂ , Pfizer Inc.,Teva Pharmaceuticals.
September 2026
The infectious disease therapeutics market size is calculated at USD 37.67 billion in 2026 and is expected to hit around USD 53.48 billion by 2035 at a CAGR of 3.97%.
September 2026
The infectious disease in-vitro diagnostics market size is valued at USD 28.78 billion in 2026 and is expected to hit around USD 35.68 billion by 2035, growing at a CAGR of 2.42%.
September 2026
The global muscle stimulator market size was calculated at USD 796.38 million in 2026 and is expected to surpass around USD 1080.71 million by 2035 with a CAGR of 3.46%.
September 2026
The global single-use filtration assemblies market size is expected to increase from USD 5.92 billion in 2026 and is estimated to hit around USD 16.19 billion by 2034 with a CAGR of 13.40%.
September 2026
The global infant resuscitators market size is estimated to hit around USD 533.97 million by 2035 increasing from USD 325.60 million in 2026, with a CAGR of 5.65%.
September 2026
The continuous glucose monitoring device market size was valued at USD 6.16 billion in 2026 and is expected to hit USD 11.23 billion by 2035, registering a CAGR of 6.94%.
September 2026
The rapid microbiology testing market size was USD 4.07 billion in 2026, with leading rapid microbiology testing market players including Accelerate Diagnostics, Inc., Becton, Dickinson and Company, Biomerieux SA, Bio-Rad Laboratories, Inc.
September 2026
The infectious respiratory disease diagnostics market size was USD 60.62 billion in 2026, with leading infectious respiratory disease diagnostics market players including F. Hoffmann - La Roche, Thermo Fisher Scientific, Danaher (Cepheid), Abbott LaboratoriesÂ
September 2026
The global central nervous system therapeutics market size is projected to hit around USD 285.72 billion by 2035 from USD 138.62 billion in 2026, with a CAGR of 8.64%
September 2026
The ear nose throat (ENT) treatment market size was estimated to hit around USD 35.15 billion by 2035 increasing from USD 21.10 billion in 2026, with a CAGR of 5.82%.
September 2026
The hemophilia treatment market was valued at USD 23.23 billion in 2026, with leading companies including Shire, CSL Behring, Grifols, S.A., Biogen Inc..
September 2026
The arteriovenous implants market is growing as innovative devices improve vascular access for dialysis and other chronic treatments.
September 2026
The global single-use surgical instruments market size is estimated to hit around USD 16.32 billion by 2035 increasing from USD 9.79 billion in 2026, with a CAGR of 5.84%.
September 2026
The global arbovirus testing market size was evaluated at USD 1.41 billion in 2026 and is predicted to hit around USD 2.16 billion by 2035, growing at a CAGR of 4.80%.
September 2026
The blood transfusion devices market size is calculated at USD 6.79 billion in 2026 and is projected to hit around USD 11.43 billion by 2035 with a CAGR of 5.97%.
September 2026
The single-use bioreactors market size is expected to increase from USD 8.61 billion in 2026 and is projected to attain around USD 38.99 billion by 2035 with a CAGR of 18.3%.
+1 650 460 3308
+61 485 981 310 +91 87933 22019
sales@precedenceresearch.com